Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Collage of Thomas Layton, Lynn Williams and Osaid Alser.

The International Dupuytren Award 2021 for Basic Research was shared between two researchers from the Kennedy Institute of Rheumatology at NDORMS. Lynn Williams was recognised for her paper "Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300" published in PNAS, and Thomas Layton for "Cellular census of human fibrosis defines functionally distinct stromal cell types and states" which appeared in Nature Communications.

The award for Best Clinical Paper award was won by Osaid Alser for the work he completed as MSc by Research student at NDORMS before graduating and moving to Harvard. His paper "Serious complications and risk of re-operation after Dupuytren’s disease surgery: a population-based cohort study of 121,488 patients in England" appeared in Nature Scientific Reports.

Dominic Furniss, who co-supervised Osaid and Thomas, said: “My congratulations go to our researchers who have been recognised for their work by the International Dupuytren Society. The research explores the underlying causes of Dupuyren’s disease and helps us move towards improving treatment for this disabling condition.”

The International Dupuytren Award recognises exceptional scientific publications on research or clinical treatment of Dupuytren and/or Ledderhose disease. 

Similar stories

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Afsie Sabokbar wins Lifetime Achievement at Teaching Excellence Awards

Director of Graduate Studies Afsie Sabokbar wins Lifetime Achievement at 2021 Teaching Excellence Awards.

NDORMS staff recognised in the 2021 Teaching Excellence Awards

Director of Graduate Studies Afsie Sabokbar, Associate Professor Stephanie Dakin and Graduate Studies Officer Samuel Burnell were all winners in the Teaching Excellence Awards.

Five ways to take action for your bone health

On World Osteoporosis Day, the International Osteoporosis Foundation (IOF), the world’s largest non-governmental organisation in the bone field, urges action for osteoporosis and fracture prevention.

NDORMS researchers awarded funding by The Paget’s Association

Professor Philippa Hulley and Doctor Helen Knowles have been awarded funding by The Paget’s Association for their research on bone cells.